Company Quick10K Filing
Nukkleus
10-Q 2021-03-31 Filed 2021-05-14
10-Q 2020-12-31 Filed 2021-02-12
10-K 2020-09-30 Filed 2020-12-28
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-15
10-Q 2019-12-31 Filed 2020-02-14
10-K 2019-09-30 Filed 2020-01-14
10-Q 2019-06-30 Filed 2019-08-20
10-Q 2019-03-31 Filed 2019-05-15
10-Q 2018-12-31 Filed 2019-02-14
10-K 2018-09-30 Filed 2018-12-20
10-Q 2018-06-30 Filed 2018-08-13
10-Q 2018-03-31 Filed 2018-05-11
10-Q 2017-12-31 Filed 2018-02-13
10-K 2017-09-30 Filed 2017-12-27
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-15
10-Q 2016-12-31 Filed 2017-02-10
10-K 2016-09-30 Filed 2017-01-13
10-Q 2016-06-30 Filed 2016-08-16
10-Q 2016-03-31 Filed 2016-05-20
10-Q 2015-12-31 Filed 2016-03-15
10-K 2015-09-30 Filed 2016-02-03
10-Q 2015-06-30 Filed 2015-09-14
10-Q 2015-03-31 Filed 2015-05-21
10-Q 2014-12-31 Filed 2015-02-23
10-K 2014-09-30 Filed 2015-01-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
8-K 2019-11-15
8-K 2019-02-25

Nukkleus Financials

NUKK Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash121390000000033149969200208258126749
Accounts Receivable
Inventory
PP&E
Assets121312000001,1771,2521,3271,3861,1051,020250270306254140324
Accounts Payable
Long-Term Debt
Liabilities181516092222321,3581,4851,6431,7211,4011,5417998158699371,0541,307
Stockholders' Equity-6-2-4-0-9-22-22-32-236-289-372-390-351-521-549-544-564-683-914-983
Income Statement ($'000)2014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue423126700006,0006,0006,0006,0004,8004,8004,8004,8004,8004,8004,800
Cost of Revenue000000005,9255,9255,9255,9254,7254,7254,7254,7254,7254,7254,725
Gross Profit293115300007575757575757575757575
R&D
SG&A1519131481401012215287-712332226978141
Tax0000000000000000000
Net Income94-2-21-8-140-10-53-83-1817-170-274-19-120-231-69
Cash Flow ($'000)2014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating1-4-340-220-1000331-30-19839-38-52-65
Cash Investing9500010-94-0-0
Cash Financing00250220000